Amphastar’s newly approved synthetic peptide product was determined by the FDA to be bioequivalent and therapeutically equivalent to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar ...

The FDA has approved the first generic equivalent of Glucagon Emergency Kit (Lilly), according to Amphastar Pharmaceuticals. Amphastar Pharmaceuticals announced that the Food and Drug ...

The FDA determined that Amphastar Pharmaceuticals' Glucagon for Injection Emergency Kit, 1 mg, a synthetic peptide product, is bioequivalent and therapeutically equivalent to Eli Lilly's ...

Amphastar gained share in this market rapidly, and we expect the company to cede share in short order. Glucagon has two primary markets: retail, in which diabetics carry glucagon emergency kits to ...

Baqsimi will give Amphastar a second emergency product for severe hypoglycemia. The company already markets a generic version of injectable glucagon for emergency kits. “The acquisition of ...

Amphastar Pharmaceuticals' generic glucagon for injection USP, 1 mg/vial, packaged in an emergency kit, is the first-ever FDA approval of a generic version of rDNA Glucagon. It is a synthetic ...

The format is potentially more convenient than traditional glucagon kits from the likes of Fresenius Kabi and Amphastar ... blood glucose don’t carry an emergency kit. Supported by Xeris ...

Amphastar Pharmaceuticals' generic glucagon for injection USP, 1 mg/vial, packaged in an emergency kit, is the first-ever FDA approval of a generic version of rDNA Glucagon. It is a synthetic ...